PGIMER Announces Round 3 Counselling Schedule For Sponsored Candidates Of INI CET January 2024

Published On 2024-02-09 06:15 GMT   |   Update On 2024-02-09 06:15 GMT
Advertisement

Chandigarh- The Postgraduate Institute of Medical Education and Research (PGIMER) Chandigarh has issued a notice announcing the upcoming 3rd physical counselling/seat allotment for candidates who applied under the sponsored category for MD/MS admission at PGIMER Chandigarh and qualified for the INI-CET (January 2024) conducted by All India Institute of Medical Sciences (AIIMS) New Delhi.

As per the notice, the third Physical Counselling/Seat Allotment is scheduled for Thursday, February 15th, 2024, at 11:00 AM in the APC Auditorium at PGIMER, Chandigarh. Candidates must be sited in the auditorium by 10:45 AM on February 15th, 2024. Later, the seats to be filled in the third counselling will be uploaded on the PGIMER website on the evening of 11 February 2024.

Advertisement

Candidates are instructed to submit one set of photocopies of certain original documents from their respective employers at the time of counselling. If the candidates fail to submit the documents they will not be considered for admission.

The documents that need to be submitted are mentioned below-

1 10th class certificate.

2 MBBS Degree.

3 Internship Certificate.

4 State Medical Council/National Medical Commission Registration Certificate.

5 Original Sponsorship Certificate.

6 No Objection Certificate (NOC).

Previously, PGIMER had announced the provisional seat allocations for the second counselling of sponsored candidates for the January 2024 session. According to the announcements, there were a total of 8 courses with a total of 30 vacant seats in the courses. Meanwhile, the second counselling session was scheduled for January 19, 2024, at 11:00 AM in the Bhargava Auditorium, PGIMER, Chandigarh.

To view the notice, click the link below-

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News